-
Anxiety Is a Predictor of Death in Middle-aged Women
-
Psychological Treatment of Depression Is Effective in the Primary Care Setting
-
The Gospel on Antipsychotic Drugs According to CATIE
-
Olanzapine may be an Effective Long-term Treatment for Bipolar Disorder
-
Key Areas for Future Research Within Child and Adolescent Psychiatry
-
Chronic Pelvic Pain: New Information on Surgical Treatment and Emotional Factors
-
Treating Schizophrenia and Related Psychotic Disorders
-
Anger and Hostility Are Associated With Worsened Coronary Heart Disease Outcomes
-
Distinguishing Between Early-Onset Persistent vs Childhood-Limited Conduct Problems in Children and Adolescents
-
Escitalopram and Sertraline Are More Efficacious and Acceptable Than Ten Other New-Generation Antidepressants
-
Stimulant Use Linked to Sudden Death in Pediatric Patients
-
What Is the Neurologist's Role in Managing Pain?
-
Autism Medication Found to be Ineffectual in Treatment of Autistic Children
-
Psychiatry Research Round-up: The Best of APA 2009
-
Recent Studies on Suicide and Suicidality -- A Video Blog With Richard H. Weisler, MD
-
Army of Volunteers Needed to Fill Gap in Mental-Health Services for Returning Veterans
-
APA 2009: Alcoholism Is Not What It Used to Be, Expert Says
-
APA 2009: Young Women Veterans at High Risk for Suicide
-
APA 2009: New Data Suggest Benefit of Deep Brain Stimulation for Refractory Depression
-
APA 2009: SADHART Shows Increased Mortality in Severely Depressed ACS Patients
Community Blogs
Commentary and Interviews
POLL
More research seems to confirm that atypical antipsychotics (AAPs) increase the risk of significant weight gain and adverse metabolic changes in pediatric patients. How regularly do you perform metabolic monitoring on your pediatric patients taking AAPs?
Advisory Board
Site Editorial Director
- A single medication with 4 indications
- ABILIFY® (aripiprazole)
- ADHD treatment: Efficacy, insights, and dosing
- AMBIEN CR® (zolpidem tartrate extended-release CIV)
- Clinical Management Center
- GEODON® (ziprasidone HCI)
- NEW INTUNIV" (guanfacine) Extended Release Tablets
- NUVIGIL® (armodafinil) Tablets [C-IV]
- PRISTIQ® (desvenlafaxine)
- Professional Liability Risk: Facts, Perspectives, and Management Strategies InfoSite
- Symbyax® (Olanzapine and Fluoxetine HCl Capsules)
- Vyvanse (lisdexamfetamine dimesylate)
Also of Interest
- House Passes Medicare SGR Fix
- First Orthopaedic Surgeon in Space to Use His Medical Skills on Mission
